Financing, Equity Capital Markets
Boundless Bio, Inc.
03/24
|
$100.0 Million
Âé¶¹´«Ã½ served as bookrunner for Boundless Bio, Inc. on its initial public offering
Sub-Type
IPO
Sector
Sub-Sector
Biopharma